Comparing add-on treatments for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active rheumatoid arthritis (not in remission).
- You are between 18 and 70 years old.
- You are currently taking a conventional DMARD (like methotrexate, sulfasalazine, or leflunomide).
- You are not taking biologic or targeted synthetic DMARDs (like Humira, Enbrel, or Xeljanz).
- You are not pregnant or breastfeeding and have no bleeding disorders or blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether desloratadine, an allergy medication, can help reduce rheumatoid arthritis symptoms when added to your current treatments. Researchers want to see if it reduces joint swelling and pain alongside your existing therapy.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This study compares two types of medication for rheumatoid arthritis to see which one might be better. It looks at how these drugs affect your daily life and physical abilities. If you have RA and are on one of these drugs, this study could help you understand your treatment better.
This study tests whether adding a Ginkgo biloba supplement to your current rheumatoid arthritis (RA) medicines can help reduce disease activity. If you have moderate to severe RA and have been on the same disease-modifying drugs for at least six months, you may qualify.
This trial tests a medical device to help people with rheumatoid arthritis stay in remission while on biologic therapy. The goal is to see if the device can prevent flares and maintain disease control.
This trial tests whether two natural plant-based medicines (diosmin and hesperidin) can reduce symptoms in people with mild to moderate rheumatoid arthritis. It compares treatment outcomes to standard care to see if these supplements help control the disease.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.